comparemela.com
  1. Home
  2. Live Updates
  3. Previously Treated Inoperable - Breaking News

Latest Breaking News On - Previously treated inoperable - Page 1 : comparemela.com

Datopotamab Deruxtecan (Dato-DXd) vs Chemotherapy for Patients with Metastatic HR+/HER2– BC: Primary Results from the Randomized Phase III TROPION-Breast01 Trial

Expert oncologist Aditya Bardia, MD, reflects on data from the TROPION-Breast01 trial of dato-DXd versus chemotherapy in metastatic HR+/HER2– breast cancer following ESMO 2023.

Aditya bardiaDatopotamab deruxtecanPrimary resultsRandomized phasePreviously treated inoperableMetastatic hormone receptor positiveBreast cancerMetastatic breast cancerHr positiveHer2 negativeTropion breast01Dato dxdEfficacy dataSafety dataAdverse eventsToxicity profile

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.